Literature DB >> 7890717

Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments.

R T Aimes1, J P Quigley.   

Abstract

The 72-kDa gelatinase/type IV collagenase (MMP-2) is a member of the matrix metalloproteinase (MMP) family of enzymes. This enzyme is known to cleave type IV collagen as well as degrade denatured collagens. However, native interstitial collagens are reportedly resistant to MMP-2 and are thought to be susceptible only to the interstitial collagenases MMP-1 and MMP-8. In this study we report that both human and chicken MMP-2, free of tissue inhibitors of metalloproteinases (TIMPs) are capable of cleaving soluble, triple helical type I collagen generating the 3/4- and 1/4-length collagen fragments characteristic of vertebrate interstitial collagenases. MMP-2 cleaves at the same Gly-Ile/Leu bond in the collagen alpha chains as interstitial collagenases with kcat and Km values similar to that of MMP-1. MMP-2 also is capable of degrading reconstituted type I collagen fibrils. The closely related 92-kDa gelatinase/type IV collagenase (MMP-9) is unable to cleave soluble or fibrillar collagen under identical conditions indicating that the specific collagenolytic activity of MMP-2 is not a general property of gelatinases. That MMP-2, a potent gelatinase, also can cleave fibrillar collagen provides an alternative to the proposal that two enzymes, an interstitial collagenase and a gelatinase, are required for the complete dissolution of stromal collagen during cellular invasion.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7890717     DOI: 10.1074/jbc.270.11.5872

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  202 in total

Review 1.  Petulant cellular acts: destroying the ECM rather than creating it.

Authors:  S M Krane
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

Review 2.  Is liver fibrosis reversible?

Authors:  R C Benyon; J P Iredale
Journal:  Gut       Date:  2000-04       Impact factor: 23.059

3.  Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: engineering cell-invasion characteristics.

Authors:  M P Lutolf; J L Lauer-Fields; H G Schmoekel; A T Metters; F E Weber; G B Fields; J A Hubbell
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-09       Impact factor: 11.205

4.  Assessment of the involvement of the macrophage migration inhibitory factor-glucocorticoid regulatory dyad in the expression of matrix metalloproteinase-2 during periodontitis.

Authors:  Josefine Hirschfeld; Mohammed Howait; Alexandru Movila; Marijo Parčina; Isabelle Bekeredjian-Ding; James Deschner; Søren Jepsen; Toshihisa Kawai
Journal:  Eur J Oral Sci       Date:  2017-08-04       Impact factor: 2.612

5.  pH- and temperature-dependence of functional modulation in metalloproteinases. A comparison between neutrophil collagenase and gelatinases A and B.

Authors:  G F Fasciglione; S Marini; S D'Alessio; V Politi; M Coletta
Journal:  Biophys J       Date:  2000-10       Impact factor: 4.033

Review 6.  Matrix metalloproteinases and descending aortic aneurysms: parity, disparity, and switch.

Authors:  Tom P Theruvath; Jeffrey A Jones; John S Ikonomidis
Journal:  J Card Surg       Date:  2011-09-29       Impact factor: 1.620

7.  Effect of 1alpha,25-dihydroxyvitamin D3 and 24R,25-dihydroxyvitamin D3 on metalloproteinase activity and cell maturation in growth plate cartilage in vivo.

Authors:  D D Dean; B D Boyan; Z Schwart; O E Muniz; M R Carreno; S Maeda; D S Howell
Journal:  Endocrine       Date:  2001-04       Impact factor: 3.633

8.  Time-resolved analysis of the matrix metalloproteinase 10 substrate degradome.

Authors:  Pascal Schlage; Fabian E Egli; Paolo Nanni; Lauren W Wang; Jayachandran N Kizhakkedathu; Suneel S Apte; Ulrich auf dem Keller
Journal:  Mol Cell Proteomics       Date:  2013-11-26       Impact factor: 5.911

9.  Regulation of type IV collagen gene expression and degradation in fast and slow muscles during dexamethasone treatment and exercise.

Authors:  A M Ahtikoski; E-M Riso; S O A Koskinen; J Risteli; T E S Takala
Journal:  Pflugers Arch       Date:  2003-12-18       Impact factor: 3.657

10.  Bone marrow-derived myofibroblasts are the providers of pro-invasive matrix metalloproteinase 13 in primary tumor.

Authors:  Julie Lecomte; Anne Masset; Silvia Blacher; Ludovic Maertens; André Gothot; Marie Delgaudine; Françoise Bruyère; Oriane Carnet; Jenny Paupert; Martin Illemann; Jean-Michel Foidart; Ida K Lund; Gunilla Høyer-Hansen; Agnes Noel
Journal:  Neoplasia       Date:  2012-10       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.